Diligence memo · auto-generated · as of July 2, 2026
Cb Therapeutics Inc.
Cb Therapeutics Inc. looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Cb Therapeutics Inc. operates in Other Health Care, based in GRAND CAYMAN.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Cb Therapeutics Inc. has raised $4.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $4.0M on 2016-07-28.
Most recent recorded round closed around 2016-07-28.
Valuation (modeled)modeled
Provath models Cb Therapeutics Inc. at approximately $99M (range $3.4M–$778M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.23× the median modeled value of Seed Other Health Care companies in 2016–2018 (222 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 9.9 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 61% of Other Health Care peers (5377 compared).
Modeled value ranks above 79% of those peers.
Closest niche peers: Eye Academy of America Ltd., Ruddco Inc., Guest House Holdings, LLC, Shift Sciences, LLC, BHCP OK4 HH/H Investors, LLC.
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.